nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—ORM1—Erlotinib—kidney cancer	0.154	0.202	CbGbCtD
Acenocoumarol—CYP3A4—Everolimus—kidney cancer	0.08	0.105	CbGbCtD
Acenocoumarol—ALB—Erlotinib—kidney cancer	0.0647	0.0849	CbGbCtD
Acenocoumarol—CYP1A2—Pazopanib—kidney cancer	0.0542	0.0712	CbGbCtD
Acenocoumarol—CYP3A4—Temsirolimus—kidney cancer	0.0541	0.071	CbGbCtD
Acenocoumarol—CYP2C9—Capecitabine—kidney cancer	0.0509	0.0669	CbGbCtD
Acenocoumarol—CYP1A2—Erlotinib—kidney cancer	0.0387	0.0508	CbGbCtD
Acenocoumarol—CYP2C19—Sorafenib—kidney cancer	0.0341	0.0448	CbGbCtD
Acenocoumarol—CYP2C9—Paclitaxel—kidney cancer	0.0319	0.0419	CbGbCtD
Acenocoumarol—CYP1A2—Sorafenib—kidney cancer	0.0315	0.0413	CbGbCtD
Acenocoumarol—CYP3A4—Pazopanib—kidney cancer	0.0284	0.0373	CbGbCtD
Acenocoumarol—CYP2C9—Sorafenib—kidney cancer	0.0283	0.0372	CbGbCtD
Acenocoumarol—CYP3A4—Erlotinib—kidney cancer	0.0203	0.0266	CbGbCtD
Acenocoumarol—CYP3A4—Paclitaxel—kidney cancer	0.0186	0.0244	CbGbCtD
Acenocoumarol—CYP3A4—Sorafenib—kidney cancer	0.0165	0.0216	CbGbCtD
Acenocoumarol—CYP3A4—Vinblastine—kidney cancer	0.0163	0.0214	CbGbCtD
Acenocoumarol—CYP3A4—Vincristine—kidney cancer	0.016	0.021	CbGbCtD
Acenocoumarol—CYP3A4—Sunitinib—kidney cancer	0.0134	0.0175	CbGbCtD
Acenocoumarol—CYP3A4—Doxorubicin—kidney cancer	0.01	0.0131	CbGbCtD
Acenocoumarol—Metrorrhagia—Pazopanib—kidney cancer	0.00481	0.0252	CcSEcCtD
Acenocoumarol—Menorrhagia—Pazopanib—kidney cancer	0.00464	0.0243	CcSEcCtD
Acenocoumarol—Skin necrosis—Paclitaxel—kidney cancer	0.00436	0.0228	CcSEcCtD
Acenocoumarol—Metrorrhagia—Everolimus—kidney cancer	0.0038	0.0199	CcSEcCtD
Acenocoumarol—CYP2C19—urine—kidney cancer	0.00377	0.182	CbGeAlD
Acenocoumarol—Menorrhagia—Everolimus—kidney cancer	0.00366	0.0192	CcSEcCtD
Acenocoumarol—Coagulopathy—Everolimus—kidney cancer	0.00348	0.0182	CcSEcCtD
Acenocoumarol—Melaena—Pazopanib—kidney cancer	0.00336	0.0176	CcSEcCtD
Acenocoumarol—Skin exfoliation—Pazopanib—kidney cancer	0.00328	0.0172	CcSEcCtD
Acenocoumarol—Metrorrhagia—Sunitinib—kidney cancer	0.00317	0.0166	CcSEcCtD
Acenocoumarol—CYP1A2—urine—kidney cancer	0.00308	0.148	CbGeAlD
Acenocoumarol—CYP2C9—urine—kidney cancer	0.00293	0.141	CbGeAlD
Acenocoumarol—Coagulopathy—Dactinomycin—kidney cancer	0.00275	0.0144	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Everolimus—kidney cancer	0.00271	0.0142	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Erlotinib—kidney cancer	0.00262	0.0137	CcSEcCtD
Acenocoumarol—Skin exfoliation—Everolimus—kidney cancer	0.00259	0.0136	CcSEcCtD
Acenocoumarol—Menorrhagia—Vincristine—kidney cancer	0.00259	0.0135	CcSEcCtD
Acenocoumarol—Melaena—Erlotinib—kidney cancer	0.00256	0.0134	CcSEcCtD
Acenocoumarol—Skin exfoliation—Erlotinib—kidney cancer	0.0025	0.0131	CcSEcCtD
Acenocoumarol—Neoplasm—Vinblastine—kidney cancer	0.00246	0.0129	CcSEcCtD
Acenocoumarol—Neoplasm—Everolimus—kidney cancer	0.00245	0.0128	CcSEcCtD
Acenocoumarol—VKORC1—renal system—kidney cancer	0.00242	0.116	CbGeAlD
Acenocoumarol—VKORC1—kidney—kidney cancer	0.00234	0.113	CbGeAlD
Acenocoumarol—Skin necrosis—Doxorubicin—kidney cancer	0.0023	0.0121	CcSEcCtD
Acenocoumarol—Ulcer—Dactinomycin—kidney cancer	0.00227	0.0119	CcSEcCtD
Acenocoumarol—Skin exfoliation—Sorafenib—kidney cancer	0.00225	0.0118	CcSEcCtD
Acenocoumarol—CYP3A4—urine—kidney cancer	0.00223	0.107	CbGeAlD
Acenocoumarol—Melaena—Sunitinib—kidney cancer	0.00221	0.0116	CcSEcCtD
Acenocoumarol—VKORC1—gonad—kidney cancer	0.00217	0.104	CbGeAlD
Acenocoumarol—Skin exfoliation—Sunitinib—kidney cancer	0.00216	0.0113	CcSEcCtD
Acenocoumarol—Neoplasm—Sorafenib—kidney cancer	0.00213	0.0111	CcSEcCtD
Acenocoumarol—Neoplasm—Sunitinib—kidney cancer	0.00205	0.0107	CcSEcCtD
Acenocoumarol—Haematuria—Temsirolimus—kidney cancer	0.00194	0.0102	CcSEcCtD
Acenocoumarol—Ulcer—Gemcitabine—kidney cancer	0.00192	0.0101	CcSEcCtD
Acenocoumarol—Haematuria—Pazopanib—kidney cancer	0.00183	0.00959	CcSEcCtD
Acenocoumarol—Metrorrhagia—Capecitabine—kidney cancer	0.00175	0.00915	CcSEcCtD
Acenocoumarol—Skin exfoliation—Gemcitabine—kidney cancer	0.00174	0.00908	CcSEcCtD
Acenocoumarol—Haemoglobin—Pazopanib—kidney cancer	0.00173	0.00907	CcSEcCtD
Acenocoumarol—Haemorrhage—Pazopanib—kidney cancer	0.00172	0.00903	CcSEcCtD
Acenocoumarol—Coagulopathy—Capecitabine—kidney cancer	0.0016	0.0084	CcSEcCtD
Acenocoumarol—Alopecia—Pazopanib—kidney cancer	0.00152	0.00798	CcSEcCtD
Acenocoumarol—Melaena—Paclitaxel—kidney cancer	0.00149	0.00778	CcSEcCtD
Acenocoumarol—Skin exfoliation—Paclitaxel—kidney cancer	0.00145	0.0076	CcSEcCtD
Acenocoumarol—Haematuria—Everolimus—kidney cancer	0.00145	0.00757	CcSEcCtD
Acenocoumarol—Neoplasm—Paclitaxel—kidney cancer	0.00138	0.0072	CcSEcCtD
Acenocoumarol—Haemoglobin—Vinblastine—kidney cancer	0.00137	0.00719	CcSEcCtD
Acenocoumarol—Haemoglobin—Everolimus—kidney cancer	0.00137	0.00716	CcSEcCtD
Acenocoumarol—Haemorrhage—Vinblastine—kidney cancer	0.00137	0.00716	CcSEcCtD
Acenocoumarol—Haemorrhage—Everolimus—kidney cancer	0.00136	0.00713	CcSEcCtD
Acenocoumarol—Haemoglobin—Erlotinib—kidney cancer	0.00132	0.00691	CcSEcCtD
Acenocoumarol—Ulcer—Capecitabine—kidney cancer	0.00132	0.00691	CcSEcCtD
Acenocoumarol—Haemorrhage—Erlotinib—kidney cancer	0.00131	0.00688	CcSEcCtD
Acenocoumarol—Melaena—Capecitabine—kidney cancer	0.00122	0.00638	CcSEcCtD
Acenocoumarol—Alopecia—Vinblastine—kidney cancer	0.00121	0.00632	CcSEcCtD
Acenocoumarol—Alopecia—Everolimus—kidney cancer	0.0012	0.0063	CcSEcCtD
Acenocoumarol—Skin exfoliation—Capecitabine—kidney cancer	0.00119	0.00624	CcSEcCtD
Acenocoumarol—Haemoglobin—Sorafenib—kidney cancer	0.00119	0.00622	CcSEcCtD
Acenocoumarol—Haemorrhage—Sorafenib—kidney cancer	0.00118	0.00619	CcSEcCtD
Acenocoumarol—Alopecia—Erlotinib—kidney cancer	0.00116	0.00608	CcSEcCtD
Acenocoumarol—Haemoglobin—Sunitinib—kidney cancer	0.00114	0.00598	CcSEcCtD
Acenocoumarol—Haemorrhage—Sunitinib—kidney cancer	0.00114	0.00595	CcSEcCtD
Acenocoumarol—Decreased appetite—Temsirolimus—kidney cancer	0.00113	0.00592	CcSEcCtD
Acenocoumarol—Neoplasm—Capecitabine—kidney cancer	0.00113	0.00591	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00112	0.00588	CcSEcCtD
Acenocoumarol—Decreased appetite—Pazopanib—kidney cancer	0.00107	0.00558	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00106	0.00554	CcSEcCtD
Acenocoumarol—Alopecia—Sorafenib—kidney cancer	0.00104	0.00547	CcSEcCtD
Acenocoumarol—Body temperature increased—Temsirolimus—kidney cancer	0.00103	0.00538	CcSEcCtD
Acenocoumarol—Alopecia—Sunitinib—kidney cancer	0.00101	0.00526	CcSEcCtD
Acenocoumarol—Haematuria—Gemcitabine—kidney cancer	0.000969	0.00507	CcSEcCtD
Acenocoumarol—Hypersensitivity—Temsirolimus—kidney cancer	0.000958	0.00502	CcSEcCtD
Acenocoumarol—Liver injury—Doxorubicin—kidney cancer	0.000957	0.00501	CcSEcCtD
Acenocoumarol—Alopecia—Dactinomycin—kidney cancer	0.000952	0.00498	CcSEcCtD
Acenocoumarol—Haemoglobin—Gemcitabine—kidney cancer	0.000917	0.0048	CcSEcCtD
Acenocoumarol—Haemorrhage—Gemcitabine—kidney cancer	0.000913	0.00478	CcSEcCtD
Acenocoumarol—Diarrhoea—Temsirolimus—kidney cancer	0.00089	0.00466	CcSEcCtD
Acenocoumarol—Ulcer—Doxorubicin—kidney cancer	0.000851	0.00445	CcSEcCtD
Acenocoumarol—Alopecia—Vincristine—kidney cancer	0.00085	0.00445	CcSEcCtD
Acenocoumarol—Decreased appetite—Vinblastine—kidney cancer	0.000844	0.00442	CcSEcCtD
Acenocoumarol—Decreased appetite—Everolimus—kidney cancer	0.000841	0.0044	CcSEcCtD
Acenocoumarol—Diarrhoea—Pazopanib—kidney cancer	0.000838	0.00439	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Everolimus—kidney cancer	0.000835	0.00437	CcSEcCtD
Acenocoumarol—Vomiting—Temsirolimus—kidney cancer	0.000827	0.00433	CcSEcCtD
Acenocoumarol—Dermatitis—Temsirolimus—kidney cancer	0.000819	0.00429	CcSEcCtD
Acenocoumarol—Haematuria—Paclitaxel—kidney cancer	0.000812	0.00425	CcSEcCtD
Acenocoumarol—Decreased appetite—Erlotinib—kidney cancer	0.000812	0.00425	CcSEcCtD
Acenocoumarol—Alopecia—Gemcitabine—kidney cancer	0.000807	0.00422	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000806	0.00422	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Doxorubicin—kidney cancer	0.000805	0.00421	CcSEcCtD
Acenocoumarol—Melaena—Doxorubicin—kidney cancer	0.000786	0.00412	CcSEcCtD
Acenocoumarol—Vomiting—Pazopanib—kidney cancer	0.000779	0.00408	CcSEcCtD
Acenocoumarol—Nausea—Temsirolimus—kidney cancer	0.000773	0.00404	CcSEcCtD
Acenocoumarol—Dermatitis—Pazopanib—kidney cancer	0.000772	0.00404	CcSEcCtD
Acenocoumarol—Skin exfoliation—Doxorubicin—kidney cancer	0.000769	0.00402	CcSEcCtD
Acenocoumarol—Haemoglobin—Paclitaxel—kidney cancer	0.000768	0.00402	CcSEcCtD
Acenocoumarol—Body temperature increased—Everolimus—kidney cancer	0.000765	0.004	CcSEcCtD
Acenocoumarol—Haemorrhage—Paclitaxel—kidney cancer	0.000764	0.004	CcSEcCtD
Acenocoumarol—CYP1A2—renal system—kidney cancer	0.000754	0.0363	CbGeAlD
Acenocoumarol—Body temperature increased—Erlotinib—kidney cancer	0.000738	0.00386	CcSEcCtD
Acenocoumarol—Decreased appetite—Sorafenib—kidney cancer	0.00073	0.00382	CcSEcCtD
Acenocoumarol—Nausea—Pazopanib—kidney cancer	0.000728	0.00381	CcSEcCtD
Acenocoumarol—Neoplasm—Doxorubicin—kidney cancer	0.000728	0.00381	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000725	0.00379	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vinblastine—kidney cancer	0.000716	0.00375	CcSEcCtD
Acenocoumarol—Hypersensitivity—Everolimus—kidney cancer	0.000713	0.00373	CcSEcCtD
Acenocoumarol—Decreased appetite—Sunitinib—kidney cancer	0.000703	0.00368	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000698	0.00365	CcSEcCtD
Acenocoumarol—Alopecia—Paclitaxel—kidney cancer	0.000675	0.00353	CcSEcCtD
Acenocoumarol—Urticaria—Sorafenib—kidney cancer	0.000667	0.00349	CcSEcCtD
Acenocoumarol—Haematuria—Capecitabine—kidney cancer	0.000666	0.00349	CcSEcCtD
Acenocoumarol—Decreased appetite—Dactinomycin—kidney cancer	0.000665	0.00348	CcSEcCtD
Acenocoumarol—Diarrhoea—Vinblastine—kidney cancer	0.000665	0.00348	CcSEcCtD
Acenocoumarol—Body temperature increased—Sorafenib—kidney cancer	0.000664	0.00347	CcSEcCtD
Acenocoumarol—Diarrhoea—Everolimus—kidney cancer	0.000662	0.00346	CcSEcCtD
Acenocoumarol—Body temperature increased—Sunitinib—kidney cancer	0.000639	0.00334	CcSEcCtD
Acenocoumarol—Diarrhoea—Erlotinib—kidney cancer	0.000639	0.00334	CcSEcCtD
Acenocoumarol—Haemoglobin—Capecitabine—kidney cancer	0.00063	0.0033	CcSEcCtD
Acenocoumarol—Haemorrhage—Capecitabine—kidney cancer	0.000627	0.00328	CcSEcCtD
Acenocoumarol—Hypersensitivity—Sorafenib—kidney cancer	0.000619	0.00324	CcSEcCtD
Acenocoumarol—Vomiting—Vinblastine—kidney cancer	0.000618	0.00323	CcSEcCtD
Acenocoumarol—Vomiting—Everolimus—kidney cancer	0.000615	0.00322	CcSEcCtD
Acenocoumarol—Dermatitis—Everolimus—kidney cancer	0.00061	0.00319	CcSEcCtD
Acenocoumarol—Body temperature increased—Dactinomycin—kidney cancer	0.000605	0.00317	CcSEcCtD
Acenocoumarol—Hypersensitivity—Sunitinib—kidney cancer	0.000595	0.00312	CcSEcCtD
Acenocoumarol—Decreased appetite—Vincristine—kidney cancer	0.000594	0.00311	CcSEcCtD
Acenocoumarol—Vomiting—Erlotinib—kidney cancer	0.000594	0.00311	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Vincristine—kidney cancer	0.00059	0.00309	CcSEcCtD
Acenocoumarol—Dermatitis—Erlotinib—kidney cancer	0.000588	0.00308	CcSEcCtD
Acenocoumarol—Nausea—Vinblastine—kidney cancer	0.000577	0.00302	CcSEcCtD
Acenocoumarol—Nausea—Everolimus—kidney cancer	0.000575	0.00301	CcSEcCtD
Acenocoumarol—Diarrhoea—Sorafenib—kidney cancer	0.000575	0.00301	CcSEcCtD
Acenocoumarol—Decreased appetite—Gemcitabine—kidney cancer	0.000564	0.00295	CcSEcCtD
Acenocoumarol—Hypersensitivity—Dactinomycin—kidney cancer	0.000564	0.00295	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00056	0.00293	CcSEcCtD
Acenocoumarol—Nausea—Erlotinib—kidney cancer	0.000555	0.0029	CcSEcCtD
Acenocoumarol—Alopecia—Capecitabine—kidney cancer	0.000554	0.0029	CcSEcCtD
Acenocoumarol—Diarrhoea—Sunitinib—kidney cancer	0.000553	0.00289	CcSEcCtD
Acenocoumarol—CYP3A4—renal system—kidney cancer	0.000546	0.0263	CbGeAlD
Acenocoumarol—Body temperature increased—Vincristine—kidney cancer	0.00054	0.00283	CcSEcCtD
Acenocoumarol—Vomiting—Sorafenib—kidney cancer	0.000534	0.00279	CcSEcCtD
Acenocoumarol—Dermatitis—Sorafenib—kidney cancer	0.000529	0.00277	CcSEcCtD
Acenocoumarol—CYP3A4—kidney—kidney cancer	0.000528	0.0254	CbGeAlD
Acenocoumarol—Diarrhoea—Dactinomycin—kidney cancer	0.000523	0.00274	CcSEcCtD
Acenocoumarol—Vomiting—Sunitinib—kidney cancer	0.000514	0.00269	CcSEcCtD
Acenocoumarol—Body temperature increased—Gemcitabine—kidney cancer	0.000513	0.00268	CcSEcCtD
Acenocoumarol—Dermatitis—Sunitinib—kidney cancer	0.000509	0.00266	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vincristine—kidney cancer	0.000504	0.00264	CcSEcCtD
Acenocoumarol—Nausea—Sorafenib—kidney cancer	0.000499	0.00261	CcSEcCtD
Acenocoumarol—Vomiting—Dactinomycin—kidney cancer	0.000486	0.00255	CcSEcCtD
Acenocoumarol—Nausea—Sunitinib—kidney cancer	0.00048	0.00251	CcSEcCtD
Acenocoumarol—Decreased appetite—Paclitaxel—kidney cancer	0.000472	0.00247	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000469	0.00245	CcSEcCtD
Acenocoumarol—Diarrhoea—Vincristine—kidney cancer	0.000468	0.00245	CcSEcCtD
Acenocoumarol—Nausea—Dactinomycin—kidney cancer	0.000454	0.00238	CcSEcCtD
Acenocoumarol—Diarrhoea—Gemcitabine—kidney cancer	0.000444	0.00232	CcSEcCtD
Acenocoumarol—Vomiting—Vincristine—kidney cancer	0.000435	0.00227	CcSEcCtD
Acenocoumarol—Urticaria—Paclitaxel—kidney cancer	0.000431	0.00226	CcSEcCtD
Acenocoumarol—Dermatitis—Vincristine—kidney cancer	0.000431	0.00225	CcSEcCtD
Acenocoumarol—Haematuria—Doxorubicin—kidney cancer	0.000429	0.00225	CcSEcCtD
Acenocoumarol—Body temperature increased—Paclitaxel—kidney cancer	0.000429	0.00225	CcSEcCtD
Acenocoumarol—Vomiting—Gemcitabine—kidney cancer	0.000412	0.00216	CcSEcCtD
Acenocoumarol—Dermatitis—Gemcitabine—kidney cancer	0.000409	0.00214	CcSEcCtD
Acenocoumarol—Haemoglobin—Doxorubicin—kidney cancer	0.000406	0.00213	CcSEcCtD
Acenocoumarol—Nausea—Vincristine—kidney cancer	0.000406	0.00212	CcSEcCtD
Acenocoumarol—Haemorrhage—Doxorubicin—kidney cancer	0.000404	0.00212	CcSEcCtD
Acenocoumarol—Hypersensitivity—Paclitaxel—kidney cancer	0.0004	0.00209	CcSEcCtD
Acenocoumarol—Decreased appetite—Capecitabine—kidney cancer	0.000387	0.00203	CcSEcCtD
Acenocoumarol—Nausea—Gemcitabine—kidney cancer	0.000385	0.00202	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000385	0.00201	CcSEcCtD
Acenocoumarol—Diarrhoea—Paclitaxel—kidney cancer	0.000371	0.00194	CcSEcCtD
Acenocoumarol—Alopecia—Doxorubicin—kidney cancer	0.000357	0.00187	CcSEcCtD
Acenocoumarol—Urticaria—Capecitabine—kidney cancer	0.000354	0.00185	CcSEcCtD
Acenocoumarol—Body temperature increased—Capecitabine—kidney cancer	0.000352	0.00184	CcSEcCtD
Acenocoumarol—Vomiting—Paclitaxel—kidney cancer	0.000345	0.00181	CcSEcCtD
Acenocoumarol—Dermatitis—Paclitaxel—kidney cancer	0.000342	0.00179	CcSEcCtD
Acenocoumarol—Hypersensitivity—Capecitabine—kidney cancer	0.000328	0.00172	CcSEcCtD
Acenocoumarol—Nausea—Paclitaxel—kidney cancer	0.000323	0.00169	CcSEcCtD
Acenocoumarol—Diarrhoea—Capecitabine—kidney cancer	0.000305	0.0016	CcSEcCtD
Acenocoumarol—Vomiting—Capecitabine—kidney cancer	0.000283	0.00148	CcSEcCtD
Acenocoumarol—Dermatitis—Capecitabine—kidney cancer	0.000281	0.00147	CcSEcCtD
Acenocoumarol—Nausea—Capecitabine—kidney cancer	0.000265	0.00139	CcSEcCtD
Acenocoumarol—Decreased appetite—Doxorubicin—kidney cancer	0.00025	0.00131	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000248	0.0013	CcSEcCtD
Acenocoumarol—Urticaria—Doxorubicin—kidney cancer	0.000228	0.00119	CcSEcCtD
Acenocoumarol—Body temperature increased—Doxorubicin—kidney cancer	0.000227	0.00119	CcSEcCtD
Acenocoumarol—Hypersensitivity—Doxorubicin—kidney cancer	0.000212	0.00111	CcSEcCtD
Acenocoumarol—Diarrhoea—Doxorubicin—kidney cancer	0.000197	0.00103	CcSEcCtD
Acenocoumarol—Vomiting—Doxorubicin—kidney cancer	0.000183	0.000956	CcSEcCtD
Acenocoumarol—Dermatitis—Doxorubicin—kidney cancer	0.000181	0.000947	CcSEcCtD
Acenocoumarol—Nausea—Doxorubicin—kidney cancer	0.000171	0.000893	CcSEcCtD
Acenocoumarol—CYP1A2—Biological oxidations—GSTP1—kidney cancer	3.05e-05	0.00114	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	3.04e-05	0.00114	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	3.01e-05	0.00113	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ACY1—kidney cancer	3e-05	0.00112	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—ITPR2—kidney cancer	2.91e-05	0.00109	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—TP53—kidney cancer	2.9e-05	0.00108	CbGpPWpGaD
Acenocoumarol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.88e-05	0.00108	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.85e-05	0.00107	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PDHB—kidney cancer	2.85e-05	0.00106	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.81e-05	0.00105	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.77e-05	0.00103	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ACY1—kidney cancer	2.74e-05	0.00102	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CCBL1—kidney cancer	2.68e-05	0.001	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.66e-05	0.000994	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.62e-05	0.000981	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.56e-05	0.000957	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PDHB—kidney cancer	2.55e-05	0.000954	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—POMC—kidney cancer	2.55e-05	0.000951	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.42e-05	0.000904	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CCBL1—kidney cancer	2.4e-05	0.000897	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.36e-05	0.000881	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ACY1—kidney cancer	2.34e-05	0.000875	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.34e-05	0.000873	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PDHB—kidney cancer	2.33e-05	0.00087	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.33e-05	0.000869	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—POMC—kidney cancer	2.32e-05	0.000867	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PPAT—kidney cancer	2.32e-05	0.000867	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GLIPR1—kidney cancer	2.32e-05	0.000867	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.29e-05	0.000856	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.27e-05	0.000847	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CCBL1—kidney cancer	2.19e-05	0.000818	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.17e-05	0.000811	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.17e-05	0.000809	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—APRT—kidney cancer	2.16e-05	0.000806	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—FH—kidney cancer	2.16e-05	0.000806	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IFNA1—kidney cancer	2.14e-05	0.000799	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.14e-05	0.000798	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.11e-05	0.000787	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.08e-05	0.000778	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PPAT—kidney cancer	2.08e-05	0.000778	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.06e-05	0.000768	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.05e-05	0.000767	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.04e-05	0.00076	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GPC3—kidney cancer	2.03e-05	0.000758	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.03e-05	0.000757	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2e-05	0.000746	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IFNA2—kidney cancer	1.99e-05	0.000744	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PDHB—kidney cancer	1.99e-05	0.000744	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—POMC—kidney cancer	1.98e-05	0.000741	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.98e-05	0.00074	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.98e-05	0.00074	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CA2—kidney cancer	1.97e-05	0.000737	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—FH—kidney cancer	1.94e-05	0.000723	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—APRT—kidney cancer	1.94e-05	0.000723	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ALAD—kidney cancer	1.92e-05	0.000718	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.91e-05	0.000715	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.91e-05	0.000714	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPAT—kidney cancer	1.9e-05	0.000709	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.9e-05	0.000709	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.89e-05	0.000707	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ST3GAL2—kidney cancer	1.88e-05	0.000701	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.87e-05	0.0007	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CCBL1—kidney cancer	1.87e-05	0.000699	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.86e-05	0.000693	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ALDH1A1—kidney cancer	1.83e-05	0.000685	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GPC3—kidney cancer	1.82e-05	0.00068	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ACY1—kidney cancer	1.81e-05	0.000675	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IGF2—kidney cancer	1.79e-05	0.00067	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CA2—kidney cancer	1.77e-05	0.000661	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APRT—kidney cancer	1.77e-05	0.000659	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—FH—kidney cancer	1.77e-05	0.000659	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PGK1—kidney cancer	1.76e-05	0.000657	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SLC5A3—kidney cancer	1.76e-05	0.000657	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALAD—kidney cancer	1.73e-05	0.000645	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.73e-05	0.000645	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—LDHB—kidney cancer	1.72e-05	0.000644	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.72e-05	0.000641	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.69e-05	0.000632	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.68e-05	0.000629	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GPC3—kidney cancer	1.66e-05	0.00062	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.65e-05	0.000615	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.62e-05	0.000606	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPAT—kidney cancer	1.62e-05	0.000606	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CA2—kidney cancer	1.61e-05	0.000603	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.6e-05	0.000598	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.59e-05	0.000592	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PGK1—kidney cancer	1.58e-05	0.00059	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.58e-05	0.00059	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALAD—kidney cancer	1.57e-05	0.000588	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—LDHB—kidney cancer	1.55e-05	0.000578	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PDHB—kidney cancer	1.54e-05	0.000574	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.54e-05	0.000574	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—POMC—kidney cancer	1.53e-05	0.000572	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.51e-05	0.000564	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—FH—kidney cancer	1.51e-05	0.000564	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APRT—kidney cancer	1.51e-05	0.000564	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.5e-05	0.000561	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CA9—kidney cancer	1.49e-05	0.000558	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.47e-05	0.000551	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.46e-05	0.000546	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.46e-05	0.000545	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CCBL1—kidney cancer	1.44e-05	0.00054	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PGK1—kidney cancer	1.44e-05	0.000538	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.44e-05	0.000538	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GPC3—kidney cancer	1.42e-05	0.00053	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—LDHB—kidney cancer	1.41e-05	0.000527	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CA2—kidney cancer	1.38e-05	0.000515	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.38e-05	0.000515	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALAD—kidney cancer	1.34e-05	0.000502	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CA9—kidney cancer	1.34e-05	0.000501	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.31e-05	0.00049	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.31e-05	0.00049	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.31e-05	0.00049	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.28e-05	0.000479	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CRABP1—kidney cancer	1.27e-05	0.000475	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPAT—kidney cancer	1.25e-05	0.000468	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.25e-05	0.000468	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PGK1—kidney cancer	1.23e-05	0.000459	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.23e-05	0.000459	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CA9—kidney cancer	1.22e-05	0.000457	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—LDHB—kidney cancer	1.21e-05	0.000451	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.2e-05	0.000447	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ITPR2—kidney cancer	1.18e-05	0.000441	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—FH—kidney cancer	1.16e-05	0.000435	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APRT—kidney cancer	1.16e-05	0.000435	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000426	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.14e-05	0.000426	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPC3—kidney cancer	1.09e-05	0.000409	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.09e-05	0.000407	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTT1—kidney cancer	1.08e-05	0.000403	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ACHE—kidney cancer	1.08e-05	0.000403	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CA2—kidney cancer	1.06e-05	0.000398	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000396	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CA9—kidney cancer	1.05e-05	0.000391	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CRABP1—kidney cancer	1.04e-05	0.000389	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALAD—kidney cancer	1.04e-05	0.000388	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.02e-05	0.000382	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SCARB1—kidney cancer	1.02e-05	0.000381	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.01e-05	0.000378	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTGS1—kidney cancer	1.01e-05	0.000377	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PSMD7—kidney cancer	9.9e-06	0.00037	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.9e-06	0.00037	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—RAF1—kidney cancer	9.87e-06	0.000369	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.78e-06	0.000365	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTT1—kidney cancer	9.67e-06	0.000361	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ACHE—kidney cancer	9.67e-06	0.000361	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ITPR2—kidney cancer	9.67e-06	0.000361	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PGK1—kidney cancer	9.49e-06	0.000355	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.49e-06	0.000355	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—BCHE—kidney cancer	9.39e-06	0.000351	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—LDHB—kidney cancer	9.31e-06	0.000348	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SLC5A5—kidney cancer	9.27e-06	0.000346	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SCARB1—kidney cancer	9.16e-06	0.000342	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTGS1—kidney cancer	9.06e-06	0.000339	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SLC2A1—kidney cancer	8.95e-06	0.000335	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.92e-06	0.000333	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CRABP1—kidney cancer	8.89e-06	0.000332	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PSMD7—kidney cancer	8.89e-06	0.000332	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IL2—kidney cancer	8.85e-06	0.00033	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ACHE—kidney cancer	8.82e-06	0.00033	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTT1—kidney cancer	8.82e-06	0.00033	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.69e-06	0.000325	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	8.54e-06	0.000319	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—BCHE—kidney cancer	8.43e-06	0.000315	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SCARB1—kidney cancer	8.35e-06	0.000312	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC5A5—kidney cancer	8.32e-06	0.000311	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ITPR2—kidney cancer	8.26e-06	0.000309	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTGS1—kidney cancer	8.26e-06	0.000309	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PSMD7—kidney cancer	8.11e-06	0.000303	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CA9—kidney cancer	8.07e-06	0.000301	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC2A1—kidney cancer	8.04e-06	0.0003	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.8e-06	0.000291	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—BCHE—kidney cancer	7.68e-06	0.000287	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.62e-06	0.000285	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.59e-06	0.000284	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.58e-06	0.000283	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTT1—kidney cancer	7.54e-06	0.000282	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ACHE—kidney cancer	7.54e-06	0.000282	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—VEGFA—kidney cancer	7.52e-06	0.000281	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTP1—kidney cancer	7.47e-06	0.000279	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.33e-06	0.000274	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SCARB1—kidney cancer	7.13e-06	0.000267	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.11e-06	0.000266	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—MAPK3—kidney cancer	7.11e-06	0.000266	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCB1—kidney cancer	7.07e-06	0.000264	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTGS1—kidney cancer	7.06e-06	0.000264	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PSMD7—kidney cancer	6.93e-06	0.000259	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTM1—kidney cancer	6.86e-06	0.000256	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CRABP1—kidney cancer	6.86e-06	0.000256	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.8e-06	0.000254	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—MAPK1—kidney cancer	6.77e-06	0.000253	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTP1—kidney cancer	6.7e-06	0.00025	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—BCHE—kidney cancer	6.57e-06	0.000245	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP1A1—kidney cancer	6.51e-06	0.000243	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.49e-06	0.000242	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—KRAS—kidney cancer	6.39e-06	0.000239	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ITPR2—kidney cancer	6.38e-06	0.000238	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCB1—kidney cancer	6.35e-06	0.000237	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.26e-06	0.000234	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.2e-06	0.000232	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTM1—kidney cancer	6.16e-06	0.00023	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTP1—kidney cancer	6.11e-06	0.000228	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.08e-06	0.000227	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CA—kidney cancer	5.87e-06	0.000219	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.84e-06	0.000218	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ACHE—kidney cancer	5.82e-06	0.000217	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTT1—kidney cancer	5.82e-06	0.000217	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCB1—kidney cancer	5.79e-06	0.000216	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TP53—kidney cancer	5.68e-06	0.000212	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTM1—kidney cancer	5.62e-06	0.00021	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SCARB1—kidney cancer	5.51e-06	0.000206	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTGS1—kidney cancer	5.45e-06	0.000204	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.35e-06	0.0002	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PSMD7—kidney cancer	5.35e-06	0.0002	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.33e-06	0.000199	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.3e-06	0.000198	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTP1—kidney cancer	5.22e-06	0.000195	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—BCHE—kidney cancer	5.07e-06	0.000189	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.01e-06	0.000187	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCB1—kidney cancer	4.95e-06	0.000185	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—POMC—kidney cancer	4.85e-06	0.000181	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.83e-06	0.000181	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTM1—kidney cancer	4.8e-06	0.000179	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.8e-06	0.000179	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.55e-06	0.00017	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.38e-06	0.000163	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—POMC—kidney cancer	4.35e-06	0.000163	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTP1—kidney cancer	4.03e-06	0.000151	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—POMC—kidney cancer	3.97e-06	0.000148	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTGS2—kidney cancer	3.87e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCB1—kidney cancer	3.82e-06	0.000143	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.74e-06	0.00014	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTM1—kidney cancer	3.71e-06	0.000138	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.51e-06	0.000131	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTGS2—kidney cancer	3.47e-06	0.00013	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—POMC—kidney cancer	3.39e-06	0.000127	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTEN—kidney cancer	3.37e-06	0.000126	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTGS2—kidney cancer	3.17e-06	0.000118	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTEN—kidney cancer	3.03e-06	0.000113	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTEN—kidney cancer	2.76e-06	0.000103	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTGS2—kidney cancer	2.71e-06	0.000101	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—POMC—kidney cancer	2.62e-06	9.78e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CA—kidney cancer	2.38e-06	8.89e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTEN—kidney cancer	2.36e-06	8.82e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.14e-06	7.98e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTGS2—kidney cancer	2.09e-06	7.8e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.95e-06	7.28e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTEN—kidney cancer	1.82e-06	6.81e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.67e-06	6.22e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.29e-06	4.8e-05	CbGpPWpGaD
